A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models
- PMID: 27476422
- PMCID: PMC4987241
- DOI: 10.1016/j.bmcl.2016.07.050
A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models
Abstract
Flavonoids are a large class of polyphenolic compounds ubiquitously distributed in dietary plants with an array of biological activities. Flavonols are a major sub-class of flavonoids featuring a hydroxyl group at C-3. Certain natural flavonols, such as quercetin and fisetin, have been shown by in vitro cell-based and in vivo animal experiments to be potential anti-prostate cancer agents. However, the Achilles' heel of flavonols as drug candidates is their moderate potency and poor pharmacokinetic profiles. This study aims to explore the substitution effect of 3-OH in flavonols on the in vitro anti-proliferative potency against both androgen-sensitive and androgen-insensitive human prostate cancer cell lines. Our first lead flavonol (3',4'-dimethoxyflavonol), eight 3-O-alkyl-3',4'-dimethoxyflavonols, and six 3-O-aminoalkyl-3',4'-dimethoxyflavonols have been synthesized through aldol condensation and the Algar-Flynn-Oyamada (AFO) reaction. The WST-1 cell proliferation assay indicates (i) that all synthesized 3-O-alkyl-3',4'-dimethoxyflavonols and 3-O-aminoalkyl-3',4'-dimethoxyflavonols are more potent than the parent 3',4'-dimethoxyflavonol and the natural flavonol quercetin in suppressing prostate cancer cell proliferation; and (ii) that incorporation of a dibutylamino group to the 3-OH group through a three- to five-carbon linker leads to the optimal derivatives with up to 292-fold enhanced potency as compared with the parent flavonol. Flow cytometry analysis showed that the most potent derivative 22 can activate PC-3 cell cycle arrest at the G2/M phase and induce PC-3 cell apoptosis. No inhibitory ability of 22 up to 50μM concentration was observed against PWR-1E normal human epithelial prostate cells, suggesting its in vitro safety profile. The results indicate that chemical modulation at 3-OH is a vital strategy to optimize flavonols as anti-prostate cancer agents.
Keywords: 3′,4′-Dimethoxyflavonol; Cell proliferation; Flavonol; Prostate cancer; Quercetin.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures






Similar articles
-
Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.Eur J Med Chem. 2018 Sep 5;157:978-993. doi: 10.1016/j.ejmech.2018.08.047. Epub 2018 Aug 22. Eur J Med Chem. 2018. PMID: 30165345 Free PMC article.
-
3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.Bioorg Med Chem. 2017 Sep 1;25(17):4768-4777. doi: 10.1016/j.bmc.2017.07.022. Epub 2017 Jul 21. Bioorg Med Chem. 2017. PMID: 28760528 Free PMC article.
-
Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.Eur J Med Chem. 2016 Feb 15;109:36-46. doi: 10.1016/j.ejmech.2015.12.041. Epub 2015 Dec 24. Eur J Med Chem. 2016. PMID: 26748997 Free PMC article.
-
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential.Biomolecules. 2019 May 6;9(5):174. doi: 10.3390/biom9050174. Biomolecules. 2019. PMID: 31064104 Free PMC article. Review.
-
Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review.Nutrients. 2022 Jun 23;14(13):2604. doi: 10.3390/nu14132604. Nutrients. 2022. PMID: 35807785 Free PMC article.
Cited by
-
Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validation.Nutr Metab (Lond). 2023 Nov 23;20(1):51. doi: 10.1186/s12986-023-00770-z. Nutr Metab (Lond). 2023. PMID: 37996895 Free PMC article.
-
Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR.Mini Rev Med Chem. 2024;24(7):721-747. doi: 10.2174/1389557523666230911141339. Mini Rev Med Chem. 2024. PMID: 37694781 Review.
-
Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents.Nutrients. 2019 Jun 29;11(7):1483. doi: 10.3390/nu11071483. Nutrients. 2019. PMID: 31261861 Free PMC article. Review.
-
Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.Nutrients. 2020 Apr 6;12(4):1010. doi: 10.3390/nu12041010. Nutrients. 2020. PMID: 32268584 Free PMC article. Review.
-
Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models.Bioorg Chem. 2019 Jun;87:227-239. doi: 10.1016/j.bioorg.2019.03.047. Epub 2019 Mar 19. Bioorg Chem. 2019. PMID: 30904813 Free PMC article.
References
-
- Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Cancer Epidemiol, Biomarkers Prev. 2003;12:665. - PubMed
-
- McCann SE, Ambrosome CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, Wilkinson GS, Graham S. Nutr Cancer. 2005;53:33. - PubMed
-
- Bosetti C, Bravi F, Talamini R, Parpinel M, Gnagnarella P, Negri E, Montella M, Lagiou P, Franceschi S, La Vecchia C. Nutr Cancer. 2006;56:123. - PubMed
-
- Geybels MS, Verhage BAJ, Arts ICW, van Schooten FJ, Goldbohm RA, van den Brandt PA. Am J Epidemiol. 2013;177:1388. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous